United States - English - NLM (National Library of Medicine)

vi medical products, inc - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51) - zinc cation 10 g in 100 ml - uses - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun. - stop use and ask a doctor if rash occurs

United States - English - NLM (National Library of Medicine)

vi medical products inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - hydroquinone 1 g in 50 ml - use - skin brightening formula that may help reduce discolorations stop and ask a doctor if skin irritation becomes severe

United States - English - NLM (National Library of Medicine)

vi medical products inc. - hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - use - skin brightening formula that may help reduce discolorations stop and ask a doctor if skin irritation becomes severe

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - salmonella typhi vi polysaccharide 25ug - solution for injection - 25µg/0.5ml - active: salmonella typhi vi polysaccharide 25ug excipient: dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate dihydrate phenol sodium chloride sodium hydroxide water for injection - typhim vi™ is indicated for active immunisation against typhoid fever caused by salmonella typhi in individuals 2 years of age and over.

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - vi polysaccharide, of salmonella, typhi - solution for injection - vi polysaccharide of salmonella typhi 25 µg - vaccines

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - salmonella typhi vi polysaccharide, quantity: 0.025 mg - injection, solution - excipient ingredients: monobasic sodium phosphate; phenol; water for injections; sodium chloride; dibasic sodium phosphate dihydrate - for the active immunisation against typhoid fever, in subjects over 5 years of age. indications as at 9 october 2000: typhim vi is indicated for active immunisation against typhoid fever in subjects 2 years of age and over.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - umeclidinium as bromide - powder for inhalation - umeclidinium as bromide 55 mcg - umeclidinium bromide - incruse is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

United States - English - NLM (National Library of Medicine)

vi medical products inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 7.5 g in 100 ml - uses - for the temporary relief of of itching associated with minor skin irritations and rashes due to - eczema - insect bites - poison ivy, poison oak, poison sumac - soaps and detergents cosmetics - jewelry stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 day or clear up and occur again within a few days, do not use this or any other hydrocortisone products unless you hav consulted a doctor.

United States - English - NLM (National Library of Medicine)

vi medical products inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - uses - for the temporary relief of of itching associated with minor skin irritations and rashes due to - eczema - insect bites - poison ivy, poison oak, poison sumac - soaps and detergents cosmetics - jewelry stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 day or clear up and occur again within a few days, do not use this or any other hydrocortisone products unless you hav consulted a doctor.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - aminolevulinic acid hydrochloride, quantity: 10.2 mg (equivalent: aminolevulinic acid, qty 8 mg) - patch, dermal - excipient ingredients: polyethylene terephthalate; polyethylene; aluminium; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - treatment of mild to moderate actinic keratoses (ak) lesions on the face and scalp (hairless areas).